Targeting Ebola Paris Committee

Scientific Committee of Targeting Ebola 2015

Pr Christian Bréchot, Director of Institut Pasteur, France

Pr Jean-François Delfraissy, French interministerial coordinator for the French national & international responses for Ebola, France

Pr François Gros, COPED, Académie des Sciences, France

Pr Gérard Orth, Académie des Sciences, Institut Pasteur, France

Pr Felix Rey, Coordinator of the Institute's Ebola Task Force, Institut Pasteur, France

Dr Reiko Suzuki, Task Force for Infectious Diseases, Tokyo Ebola Group, Japan 

 


 

Ebola Tokyo Group Committee
We are more than 165 members coming from Japan, China and other countries. We are an interdisciplinary group where scientists, economists, humanists, psychologists exhange ideas and strategies.

The Task force for Infectious Diseases aims was intended to help and promote high-level policy dialogue amongst many countries, institutions and organizations. It emerged in 2005 after the outbreak of many infectious diseases. TID has evolved into a major global TASKFORCE to promote development between developing and riches countries. 

Our aim is to combat infectious diseases in many countries, thus contributing to the health and welfare of people and of all humankind. We will 
coordinate strategies to prevent and treat HIV, AIDS, mers, tuberculosis and malaria.

Task Force for Infectious Diseases Group is located in Japan, with bi-annual meetings. 

Different groups dedicated to each infectious diseases:
- Malaria group
- Tuberculosis and Plague group
- HIV group
- Influenza Group
- Ebola group 

Task Forces for Infectious Diseases Committee

- R. Suzuki, Japan
- K. Shimono, Japan
- S. Kabe, Japan
- K. Choi, Korea
- N. Nakamoto, Japan
- W. Wu, China
- X. Qiu, China
- S. Uta, Japan
- H. Wang, Taiwan
- S. Maeng, Korea
- H. Hirata, Japan


TASK FORCE INFECTIOUS DISEASE - Ebola Tokyo Group

Dr Reiko Suzuki

Email: ebola (at) targeting-ebola.com

 


logo-Task-force-japan

We must stop watching and act energetically ...

TID Aim : Affect the differences between rich and poor countries with respect to causes of death?


In high-income countries
, 7 in every 10 deaths are among people aged 70 years and older. People predominantly die of chronic diseases: cardiovascular diseases, cancers, dementia, chronic obstructive lung disease or diabetes. Lower respiratory infections remain the only leading infectious cause of death. Only 1 in every 100 deaths is among children under 15 years.


In low-income countries
, nearly 4 in every 10 deaths are among children under 15 years, and only 2 in every 10 deaths are among people aged 70 years and older. People predominantly die of infectious diseases: lower respiratory infections, HIV/AIDS, diarrhoeal diseases, malaria and tuberculosis collectively account for almost one third of all deaths in these countries. Complications of childbirth due to prematurity, and birth asphyxia and birth trauma are among the leading causes of death, claiming the lives of many newborns and infants.


Can we talk about Death ?

HIV deaths decreased slightly from 1.7 million (3.2%) deaths in 2000 to 1.5 million (2.7%) deaths in 2012. Diarrhoea is no longer among the 5 leading causes of death, but is still among the top 10, killing 1.5 million people in 2012. Tuberculosis, while no longer among the 10 leading causes of death in 2012, was still among the 15 leading causes, killing over 900 000 people in 2012.


How many young children die each year, and why?

In 2012, 6.6 million children died before reaching their fifth birthday; almost all (99%) of these deaths occurred in low- and middle-income countries. The major killers of children aged less than 5 years were prematurity, pneumonia, birth asphyxia and birth trauma, and diarrhoeal diseases. Malaria was still a major killer in sub-Saharan Africa, causing about 15% of under 5 deaths in the region.

Malaria : The forgotten tragedy

Malaria is one of our priorities for 2015.

Malaria
is a mosquito-borne infectious disease of humans and other animals caused by parasitic protozoans of the Plasmodium type. Malaria is one of the most severe public health problems worldwide. It is a leading cause of death and disease in many developing countries, where young children and pregnant women are the groups most affected. According to the World Health Organization’s World Malaria Report 2013 and the Global Malaria Action Plan

  • 3.4 billion people (half the world’s population) live in areas at risk of malaria transmission in 106 countries and territories
  • In 2012, malaria caused an estimated 207 million clinical episodes, and 627,000 deaths. An estimated 91% of deaths in 2010 were in the African Region.

We will put together pharmaceuticals companies and political institutions to talk about practical issues to progress in this dramatic situation.


Avian influenza: H5N8-H5N9 


Known informally as avian flu or bird flu — refers to "influenza caused by viruses adapted to birds. The version with the greatest concern is highly pathogenic avian influenza (HPAI).

The newest avian influenza strain, H5N8-H5N9, is spreading throughout Europe with cases confirmed in German, the Netherlands, and Britain. The first outbreak started at a turkey farm in Germany around November 6. This strain is very similar to one labeled H5N6 that arose in China, Republic of Korean, and Japan earlier this year.

Two meetings already organized in 2006 and 2007 about Avian influenza at Pateur Institute in Paris.

Ebola and others Filoviruses

Filoviruses is a family of viruses of which the most commonly known members are Ebola virus and Marburg virus. Both viruses cause severe, usually lethal haemorrhagic fever in humans.
Filoviruses differ from dengue and other haemorrhagic fevers due to the fact that they can spread directly from person to person, where many other haemorrhagic fevers require an intermediate host, like a mosquito, to spread the disease.
Ebola virus disease (EVD), previously known as Ebola haemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strains. It has an incubation period of 2-21 days, and it usually begins as a sudden influenza-like syndrome, which rapidly progresses to multi-organ failure and coagulation abnormalities which manifest as internal and external haemorrhages.


The World Health Organization (WHO) was notified on March 23, 2014, of an outbreak of EVD in Guinea. The disease soon spread to the bordering countries of Liberia and Sierra Leone, which are the most severely affected countries. On August 8, 2014, the epidemic was declared a “public health emergency of international concern” (ref WHO Ebola Response Team, NEJM 2014, 371, 1481). Suspected cases of EVD have since been reported in seven affected countries (Guinea, Liberia, Nigeria, Senegal, Sierra Leone, Spain, and the United States of America). Unprecedented in scale and geographical distribution since the identification of Ebola in 1976, the current epidemic has an apparent overall case-fatality ratio of about 70%; but it is suspected that many more cases have gone unrecorded. The WHO reported on October 14, 2014 that the number of new Ebola cases could reach 10,000 per week by December 2014. On October 31, more than 5000 deaths and 13.567 cases had been reported in Sierra Leone, Liberia and Guinea, according to the WHO.

Noguchi Laigret

Targeting Ebola 2015 is dedicated to the memory of Dr Hideyo Noguchi and Dr Jean Laigret


For more information, please click here.

 






TASK FORCE INFECTIOUS DISEASE - Ebola Tokyo Group

Dr Reiko Suzuki

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 

TARGETING EBOLA WORLD CONGRESS WAS A HUGE SUCCESS